Dilip Jha

Dilip Jha

Auto-generated profile, based on publicly available information

Dilip Jha

Clinical Trials, Centre for Chronic Disease Control, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2019 in Circulation
Verified
Journal Article
Open access
DPDorairaj Prabhakaran
Dorairaj Prabhakaran
DJDilip Jha
Dilip Jha
DPDavid Prieto-Merino
David Prieto-Merino
ARAmbuj Roy
Ambuj Roy
KSKavita Singh
Kavita Singh
VPVikram Patel
Vikram Patel
Background: The burden of noncommunicable diseases and their risk factors has rapidly increased worldwide, including in India. Innovative management strategies with electronic decision support and task sharing have been assessed for hypertension, diabetes mellitus, and depression individually, but an integrated package for multiple chronic condition management in primary care has not been evaluated. Methods: In a prospective, multicenter, open-label, cluster-randomized controlled trial involving 40 community health centers, using hypertension and diabetes mellitus as entry points, we evaluated the effectiveness of mWellcare, an mHealth system consisting of electronic health record storage and an electronic decision support for the integrated management of 5 chronic conditions (hypertension, diabetes mellitus, current tobacco and alcohol use, and depression) versus enhanced usual care among patients with hypertension and diabetes mellitus in India. At trial end (12-month follow-up), using intention-to-treat analysis, we examined the mean difference between arms in change in systolic blood pressure and glycated hemoglobin as primary outcomes and fasting blood glucose, total cholesterol, predicted 10-year risk of cardiovascular disease, depression score, and proportions reporting tobacco and alcohol use as secondary outcomes. Mixed-effects regression models were used to account for clustering and other confounding variables. Results: Among 3698 enrolled participants across 40 clusters (mean age, 55.1 years; SD, 11 years; 55.2% men), 3324 completed the trial. There was no evidence of difference between the 2 arms for systolic blood pressure (Δ=−0.98; 95% CI, −4.64 to 2.67) and glycated hemoglobin (Δ=0.11; 95% CI, −0.24 to 0.45) even after adjustment of several key variables (adjusted differences for systolic blood pressure: – 0.31 [95% CI, −3.91 to 3.29]; for glycated hemoglobin: 0.08 [95% CI, −0.27 to 0.44]). The mean within-group changes in systolic blood pressure in mWellcare and enhanced usual care were −13.65 mm Hg versus −12.66 mm Hg, respectively, and for glycated hemoglobin were −0.48% and −0.58%, respectively. Similarly, there were no differences in the changes between the 2 groups for tobacco and alcohol use or other secondary outcomes. Conclusions: We did not find an incremental benefit of mWellcare over enhanced usual care in the management of the chronic conditions studied. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02480062.

1 January 2018 in Global Health Action
Verified
Journal Article
Open access
DJDevraj Jindal
Devraj Jindal
PGPriti Gupta
Priti Gupta
DJDilip Jha
Dilip Jha
VAVamadevan S. Ajay
Vamadevan S. Ajay
SGShifalika Goenka
Shifalika Goenka
VPVikram Patel
Vikram Patel
Background: Cardiovascular diseases and diabetes are among the leading causes of premature adult deaths in India. Innovative approaches such as clinical decision support (CDS) software could play a major role in improving the quality of hypertension/diabetes care in primary care settings. Objective: To describe the steps and processes in the development of mWellcare, a complex intervention based on mobile health (mHealth) technology. Methods: The Medical Research Council framework was used to develop mWellcare in four steps: (1) identify gaps in usual care through literature review and health facility assessments; (2) identify the components of the intervention through discussions and consultations with experts; (3) develop intervention (clinical algorithms and mHealth system); and (4) evaluate acceptability and feasibility through pilot testing in five community health centers. Results: Lack of evidence-based, integrated, and systematic management of chronic conditions were major gaps identified. Experts in information technology, clinical fields, and public health professionals identified intervention components to address these gaps. Thereafter, clinical algorithm contextualized to primary care settings were prepared and the mWellcare intervention was developed. During the 2-month pilot, 631 patients diagnosed with hypertension and/or diabetes were registered, with a follow-up rate of 36.2%. The major barrier was resistance to follow mWellcare recommended patient workflow, and to overcome it, we emphasized onsite training and orientation program to cover all health care team member in each CHC. Conclusion: A pilot-tested mWellcare intervention is an mHealth system with important components, i.e. integrated management of chronic conditions, evidence-based CDS, longitudinal health data and automated short-messaging service to reinforce compliance to drug intake and follow-up visit, which will be used by nurses at primary health care settings in India. The effectiveness and cost-effectiveness of the intervention will be tested through a cluster randomized trial (trial registration number NCT02480062).

18 October 2016 in Endocrine Abstracts
Verified
Journal Article
Closed access
DJDevraj Jindal
Devraj Jindal
DJDilip Jha
Dilip Jha
PGPriti Gupta
Priti Gupta
AVAjay S. Vamadevan
Ajay S. Vamadevan
ARAMBUJ ROY
AMBUJ ROY
DPDorairaj Prabhakaran
Dorairaj Prabhakaran
Background: Diabetes and hypertension are among leading causes of premature adult deaths in India. Innovative approaches such as electronic clinical decision support systems (DSS) could play major role in improving quality and access to diabetes and hypertension care at primary care settings. Objective: The main objective of this study is to develop an innovative tablet-computer based DSS namely “m-WELLCARE”, and other essential support healthcare processes for facilitating evidence-based diabetes and hypertension care at primary care. Methods: A multidisciplinary team of researchers, clinicians, administrators and software experts used mixed methods to design and develop the mWellcare in six iterative steps: 1) Literature review and expert consultation; 2) Needs assessment; 3) Adapting the clinical management guideline to local context; 4) Validation of clinical algorithms 5) Identifying support healthcare processes and 6) Field testing of the mWellcare at five Community Health Centers in India. Results: The above steps provided inputs for designing core-features of the DSS which include: Computation of personalized evidence-based management plan for diabetes, hypertension and co-morbid conditions (depression and alcohol use disorder); Assessment of cardiovascular risk using a re-calibrated Framingham-Risk function; Graphical display of patient clinical parameters; Minimum or nil chance of duplicate records; Access to patient’s previous visit records; Case data sharing between doctors and nurses electronically or through printout; and Short Message Service reminder for the patients. Conclusion: Development of electronic DSS for diabetes and hypertension care for the use at resource poor settings is a complex process. Learning from this study can serve as resource for developing similar applications for decision support enabled interventions.